BMJ Open Diabetes Research & Care · 2020 · 45 citations · 24 references
Life SciencesNutritionNutritional SciencesMetabolic RegulationMicrobial MetabolismMicrobial PhysiologyDiabetes MellitusGut MicrobiotaInsulin ResistanceLactic Acid BacteriaProbioticsGlucose Transporter 2Glycemic DysregulationIntestinal Glucose UptakeLactic Acid Bacteria ProbioticsMonosaccharide TransportersProbiotic Effects On AbsorptionProbiotic Effects On Gut MicrobiotaProbiotic Microorganisms
Objectives Patients with type 2 diabetes mellitus (T2DM) exhibit strong insulin resistance or abnormal insulin production. Probiotics, which are beneficial live micro-organisms residing naturally in the intestinal tract, play indispensable roles in the regulation of host metabolism. However, the detailed mechanisms remain unclear. Here, we evaluate the mechanisms by which probiotic strains mediate glycemic regulation in the host. The findings should enable the development of a safe and natural treatment for patients with T2DM. Research designs and methods Sugar consumption by more than 20 strains of Lactobacillus species was first evaluated. The probiotic strains that exhibited high efficiency of sugar consumption were further coincubated with Caco-2 cells to evaluate the regulation of sugar absorption in gut epithelial cells. Finally, potential probiotic strains were selected and introduced into a T2DM animal model to study their therapeutic efficacy. Results Among the tested strains, Lactobacillus salivarius AP-32 and L. reuteri GL-104 had higher monosaccharide consumption rates and regulated the expression of monosaccharide transporters. Glucose transporter type-5 and Na + -coupled glucose transporter mRNAs were downregulated in Caco-2 cells after AP-32 and GL-104 treatment, resulting in the modulation of intestinal hexose uptake. Animal studies revealed that diabetic mice treated with AP-32, GL-104, or both showed significantly decreased fasting blood glucose levels, improved glucose tolerance and blood lipid profiles, and attenuated diabetes-mediated liver and kidney injury. Conclusion Our data elucidate a novel role for probiotics in glycemic regulation in the host. L. salivarius AP-32 and L. reuteri GL-104 directly reduce monosaccharide transporter expression in gut cells and have potential as therapeutic probiotics for patients with T2DM.
24
Sarah H. Wild, Gojka Roglić, Anders Green et al. · Diabetes Care · 2004 · 15.3K citations
Molecular Characterisation of the Faecal Microbiota in Patients with Type II Diabetes
Xiaokang Wu, Chaofeng Ma, Lei Han et al. · Current Microbiology · 2010 · 460 citations
Immunomodulatory mechanisms of lactobacilli
Jerry M. Wells · Microbial Cell Factories · 2011 · 419 citations · Full text
The Role of SGLT1 and GLUT2 in Intestinal Glucose Transport and Sensing
Pia V. Röder, Kerstin E. Geillinger, Tamara Zietek et al. · PLoS ONE · 2014 · 400 citations · Full text
Lívia Bordalo Tonucci, Karina Maria Olbrich dos Santos, Leandro Licursi de Oliveira et al. · Clinical Nutrition · 2015 · 386 citations